Arrhythmia Disorders News

Healio | Cardiology Today compiled a list of the top headlines in cardiology of January 2024.

The FDA approved a second pulsed field ablation system for the treatment of adults with drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.

Sudden death from cardiac causes is among the leading causes of death in the United States, yet predicting who might be at high risk remains a difficult task.

When children aged 8 to 15 years were screened for risk for before participating in sports, the diagnostic yield for identifying those at risk was higher in those aged 12 years or older, researchers reported.

The antipsychotic drugs quetiapine and haloperidol were associated with severe QT prolongation, ventricular arrhythmias and sudden cardiac death, researchers reported in HeartRhythm.

Healio | Cardiology Today Editorial Board Member Bruce L. Wilkoff, MD, FACC, FHRS, FAHA, an electrophysiologist who performed groundbreaking research in lead extraction, has died, Cleveland Clinic and the Heart Rhythm Society announced.

A review of electronic medical records show the Apple Watch detected heart rhythm abnormalities in children that led to a new arrhythmia diagnosis for some, and also recorded some arrhythmias that traditional ambulatory monitors did not.

Medical cannabis use for chronic pain may confer increased risk for de novo arrhythmia compared with nonuse or other treatments for chronic pain, researchers in Denmark reported.

CVRx Inc. announced the FDA approved its revised instructions for use for its baroreflex activation therapy device incorporating clinical data from the BeAT-HF randomized clinical trial.

Insertable cardiac monitors with capability for remote reprogramming were associated with a clinic workflow improvement of 211 hours per 100 patients, data from a real-world analysis show.